Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Exanthema 2Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1Sezary Syndrome 1Recurrence 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pneumonia, Pneumocystis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neoplasms, Plasma Cell 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Multiple Myeloma 1Methemoglobinemia 1Lymphoproliferative Disorders 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukoplakia, Oral 1Leukemia, Prolymphocytic 1Leukemia, Neutrophilic, Chronic 1

Interventions

Photochemotherapy 3Metformin 3Biopsy 3Pioglitazone 2Aminolevulinic Acid 2Tomography, Optical Coherence 1Tobacco Products 1Surveys and Questionnaires 1Sulindac 1Specimen Handling 1Rosiglitazone 1Photosensitizing Agents 1Nivolumab 1Melatonin 1Gene Expression Profiling 1Fluorouracil 1Fluconazole 1Ethanol 1Dihematoporphyrin Ether 1Dapsone 1Celecoxib 1Catechin 1Behavior Therapy 1Aspirin 1Acyclovir 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukoplakia, Oral × Dapsone × Clear all
NCT00002043 2005-06-24

Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC)

NIH AIDS Clinical Trials Information Service

Phase NA Completed
Head & Neck

AIDS-Related Complex, Candidiasis, Oral, Leukoplakia, Oral, Pneumonia, Pneumocystis, HIV Infections, AIDS-Related Opportunistic Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡